Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events

Autor: Emmanuel Teiger, Jean-Benoit Thambo, Pascal Defaye, Jean-Sylvain Hermida, Sélim Abbey, Didier Klug, Jean-Michel Juliard, Jean-Luc Pasquie, Gilles Rioufol, Antoine Lepillier, Meyer Elbaz, Jerome Horvilleur, Philippe Brenot, Bertrand Pierre, Philippe Le Corvoisier, Nicolas Amabile, Marian Andronache, Frederic Anselme, Sebastien Armero, Pierre Aubry, Etienne Audureau, Dominique Babuty, Babe Bakouboula, Clement Bars, Alban-Elouen Baruteau, Jacques Bille, Jean-Louis Bonnet, Francois Brigadeau, Eric Brochet, Sok-Sithikun Bun, Guillaume Cailla, Olivier Cesari, Didier Champagnac, Philippe Chevalier, Nicolas Combes, Bertrand Comet, Philippe Commeau, Jean-Claude Dearo, Antoine Dompnier, Bruno Farah, Philippe Garot, Daniel Gras, Cedric Giraudeau, Mathieu Granier, Patrice Guerin, Xavier Iriart, Zakaria Jalal, Laurence Jesel-Morel, Antoine Jeu, Priscille Kamtchueng, Nicolas Lellouche, Nicolas Meneveau, Norbert Nighoghossian, Akli Otmani, Remy Pelliere, Remy Pillière, Maxime Pons, Batric Popovic, Pénélope Pujadas, Roland Rossi, Antoine Roux, Yannick Saludas, Christian Spaulding, Victor Statiev, Julien Ternacle, Sarah Traulle, Pierre-François Winum

Publikováno v: Circulation: Cardiovascular Interventions
Circulation: Cardiovascular Interventions, American Heart Association, 2018, 11 (3), pp.e005841. ⟨10.1161/CIRCINTERVENTIONS.117.005841⟩

Background— Percutaneous left atrial appendage (LAA) closure is an emerging option for patients with atrial fibrillation at high risk for cerebrovascular events. The multicenter FLAAC registry (French Nationwide Observational LAA Closure Registry)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489f8e65c194e50381ba6dc1889b23ac
https://hal.umontpellier.fr/hal-01788824/document

High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation

Autor: Raphaël Decoin, Laura Butruille, Thomas Defrancq, Jordan Robert, Nicolas Destrait, Augustin Coisne, Samy Aghezzaf, Eloise Woitrain, Zouriatou Gouda, Sofia Schino, Cédric Klein, Patrice Maboudou, François Brigadeau, Didier Klug, Andre Vincentelli, David Dombrowicz, Bart Staels, David Montaigne, Sandro Ninni

Publikováno v: Frontiers in Endocrinology, Vol 13 (2022)

BackgroundA number of epidemiological studies have suggested an association between metabolic dysfunction-associated fatty liver disease (MAFLD) and the incidence of atrial fibrillation (AF). However, the pathogenesis leading to AF in the context of

Externí odkaz: https://doaj.org/article/a64a1b19696149678774d238dc4c9c47